Combining virotherapy and angiotherapy for the treatment of breast cancer.
A breast cancer-selective oncolytic adenovirus was engineered to express antagonists of vascular endothelial growth factor (VEGF) and Notch signaling to combine direct anticancer activity with disruption of tumor-associated angiogenesis. Replication of the parental virus, AdEHE2F, is stimulated by e...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|
Search Result 1
Combining virotherapy and angiotherapy for the treatment of breast cancer
Published 2013
Journal article